Efficacy of a bacterial extract (OM-85 BV) in preventing recurrent respiratory tract infections in susceptible children

Clinical Drug Investigation

Volumn 13, Issue 2, 1997, Pages 76-84

  Gutiérrez Tarango, María Dolores ^a   Berber, Arturo ^b  

^a Pediat Serv Pensiones Civiles E   (Mexico)

^b BASF Mexicana SA de CV   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; IMMUNOSTIMULATING AGENT;

ANTIMICROBIAL THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; ORAL DRUG ADMINISTRATION; OTITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

EID: 0031044293     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199713020-00003     Document Type: Article

References (26)

1. Haskins R, Kotch J. Day care and illness: evidence, costs, and public policy. Pediatrics 1986; Suppl. 2: 951-82
2. Bell DM, Gleiber DW. Mercer AA, et al. Illness associated with child day care: a study of incidence and cost. Am J Public Health 1989; 79: 479-84
3. Bale JR. Creation of a research program to determine the etiology and epidemiology of acute respiratory tract infection among children in developing countries. Rev Infect Dis 1990; 12 Suppl. 8: S861-6
4. Wald ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics 1991; 87: 129-33
5. Erwick-Roberts J, Burchinal MR, Collier AM, et al. Otitis media in early childhood and cognitive, academic and classroom performance of the school-aged child. Pediatrics 1989; 83: 477-85
6. Loda FA, Glezen WP, Clyde WA. Respiratory disease in around day care. Pediatrics 1972; 49: 428-37
7. Dingle JH, Badger GF, Jordan WJ. Illness in the home. Cleveland, Ohio; Press of Case Western Reserve University, 1964
8. Selwyn BJ. The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Rev Infect Dis 1990; 12 Suppl. 8: S870-88
9. Wald ER, Guerra N, Byers C. Frequency and severity of infections in day care: three-year follow-up. J Pediatr 1991; 118: 509-14
10. Hurwitz ES, Gunn WJ, Pinsky PF, et al. Risk of respiratory illness associated with day-care attendance: a nationwide study. Pediatrics 1991; 87: 62-9
11. Fleming DW, Cochi SL, Hightower AW, et al. Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatrics 1987; 79: 55-60
12. Anderson LJ, Parker RA, Strikas RA, et al. Day-care center attendance and hospitalization for lower respiratory tract illness. Pediatrics 1988; 82: 300-8
13. Soderstrom M, Hovelius B, Prellner K. Respiratory tract infections in children with recurrent episodes as preschoolers. Acta Paediatr Scand 1991; 80: 688-95
14. De Baets F, Kint J, Pauwels R, et al. IgG subclass deficiency in children with recurrent bronchitis. Eur J Pediatr 1992; 151: 274-8
15. Mauël J, Stimulation of immuno-protective mechanisms by OM-85 BV. Respiration 1994; 61 Suppl. 1: 8-15
16. Mauël J, Van Pham T, Kreis B, et al. Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages. Int J Immunopharmacol 1989; 11: 637-45
17. Emmerich B, Emslander HP, Pachmann K, et al. Local immunity in patients with chronic bronchitis and the effects of a bacterial extract. Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables. Respiration 1990; 57: 90-9
18. Lusuardi M, Capelli A, Carli S, et al. Local airways immune modifications induced by oral bacterial extracts in chronic bronchitis. Chest 1993; 103: 1783-91
19. Paupe J. Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections. Respiration 1991; 58: 150-4
20. Collet J-P, Ducruet T, Kramer MS. et al. Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. Pediatr Infect Dis J 1993; 12: 648-52
21. Grove AK, Bergemann R, Keller R. Preventive treatment of chronic bronchitis: a cost-effectiveness analysis for an immunoactive bacterial extract in Switzerland. Br J Med Econ 1996; 10: 1-14
22. Aymard M, Chomel JJ, Allard JP, et al. Epidemiology of viral infections and evaluation of the potential benefit of OM-85 BV on the virology status of children attending day-car centers. Respiration 1994; 61 Suppl. 1: 24-31
23. Puigdollers JM, Serna GR, Hernández del Rey I, et al. Immunoglobulin production in man stimulated by orally administered bacterial lysate. Respiration 1980; 40: 142-9
24. Fitzgerald L. Exercise and the immune system. Immunol Today 1988; 9: 337-9
25. Jemmott JB, McClelland DC. Secretory IgA as a measure of resistance to infectious disease: comments on Stone, Cox, Valdimarsdottir and Neale. Behav Med 1989; 15: 63-71
26. Rossen RD, Butler WT, Waldman RH, et al. The proteins in nasal secretion. II. A longitudinal study of IgA and neutralizing antibody levels in nasal washing from men infected with influenza virus. JAMA 1970; 211: 1157-61